Table 3. Competing risk regression... | American Society of Hematology

Table 3.

Competing risk regression models of ON and fracture

Variable	Univariate, HR [95% CI]	P	Multivariable, HR [95% CI]	P
ON
Treatment regimen, late vs early	5.28 [2.24-12.48]	<.001	5.08 [2.12-12.16]	<.001
Age
<30 vs 30-50 y	2.77 [1.35-5.65]	.005	2.58 [1.26-5.30]	.010
BMI
Morbidly obese/obese vs underweight/normal	0.81 [0.41-1.60]	.55	0.92 [0.46-1.84]	.82
Overweight vs underweight/normal	0.70 [0.36-1.34]	.28	0.97 [0.51-1.86]	.94
Sex
Male vs female	0.85 [0.51-1.41]	.52	0.84 [0.50-1.40]	.51
Fracture
Treatment regimen, late vs early	1.12 [0.57-2.17]	.75	1.12 [0.57-2.20]	.74
Age
<30 vs 30-50 y	1.25 [0.63-2.50]	.52	1.18 [0.54-2.57]	.68
BMI
Morbidly obese/obese vs underweight/normal	0.72 [0.31-1.67]	.45	0.78 [0.32-1.87]	.58
Overweight vs underweight/normal	0.58 [0.25-1.32]	.19	0.66 [0.27-1.64]	.37
Sex
Male vs female	0.55 [0.29-1.02]	.057	0.56 [0.29-1.08]	.084

Variable	Univariate, HR [95% CI]	P	Multivariable, HR [95% CI]	P
ON
Treatment regimen, late vs early	5.28 [2.24-12.48]	<.001	5.08 [2.12-12.16]	<.001
Age
<30 vs 30-50 y	2.77 [1.35-5.65]	.005	2.58 [1.26-5.30]	.010
BMI
Morbidly obese/obese vs underweight/normal	0.81 [0.41-1.60]	.55	0.92 [0.46-1.84]	.82
Overweight vs underweight/normal	0.70 [0.36-1.34]	.28	0.97 [0.51-1.86]	.94
Sex
Male vs female	0.85 [0.51-1.41]	.52	0.84 [0.50-1.40]	.51
Fracture
Treatment regimen, late vs early	1.12 [0.57-2.17]	.75	1.12 [0.57-2.20]	.74
Age
<30 vs 30-50 y	1.25 [0.63-2.50]	.52	1.18 [0.54-2.57]	.68
BMI
Morbidly obese/obese vs underweight/normal	0.72 [0.31-1.67]	.45	0.78 [0.32-1.87]	.58
Overweight vs underweight/normal	0.58 [0.25-1.32]	.19	0.66 [0.27-1.64]	.37
Sex
Male vs female	0.55 [0.29-1.02]	.057	0.56 [0.29-1.08]	.084